Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Cullinan Therapeutics, Inc.(CGEM) | 7,648,268 | 7,648,268 | 0 | $57.90M | $57.59M | 9.98% | -$305.9K |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 100,415 | 100,415 | 0 | $33.26M | $30.39M | 5.27% | -$2.87M |
| Zai Lab LimitedADR(ZLAB) | 833,659 | 745,060 | -88,599 | $30.13M | $26.05M | 4.51% | -$4.07M |
| Guardant Health, Inc.(GH) | 442,656 | 442,656 | 0 | $18.86M | $23.04M | 3.99% | +$4.18M |
| ARS Pharmaceuticals, Inc.(SPRY) | 1,313,104 | 1,303,399 | -9,705 | $16.52M | $22.74M | 3.94% | +$6.23M |
| Edgewise Therapeutics, Inc.(EWTX) | 1,105,444 | 1,720,741 | +615,297 | $24.32M | $22.56M | 3.91% | -$1.76M |
| Avidity Biosciences Inc | 714,224 | 760,022 | +45,798 | $21.08M | $21.58M | 3.74% | +$500.7K |
| PTC Therapeutics, Inc.(PTCT) | 439,977 | 438,477 | -1,500 | $22.42M | $21.42M | 3.71% | -$1.01M |
| Trevi Therapeutics, Inc.(TRVI) | 3,428,366 | 3,406,955 | -21,411 | $21.56M | $18.64M | 3.23% | -$2.93M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 1,399,514 | 1,729,378 | +329,864 | $7.81M | $17.55M | 3.04% | +$9.74M |
| Natera, Inc.(NTRA) | 157,047 | 98,924 | -58,123 | $22.21M | $16.71M | 2.90% | -$5.50M |
| Alkermes plc(ALKS) | 337,603 | 549,262 | +211,659 | $11.15M | $15.71M | 2.72% | +$4.57M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 316,049 | 313,571 | -2,478 | $12.35M | $14.80M | 2.56% | +$2.45M |
| MBX Biosciences, Inc.(MBX) | 1,132,950 | 1,294,416 | +161,466 | $8.36M | $14.77M | 2.56% | +$6.41M |
| Compass Therapeutics, Inc.(CMPX) | 8,442,783 | 5,622,505 | -2,820,278 | $16.04M | $14.62M | 2.53% | -$1.42M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 398,445 | 395,700 | -2,745 | $14.43M | $14.39M | 2.49% | -$40.0K |
| Janux Therapeutics, Inc.(JANX) | 567,193 | 614,282 | +47,089 | $15.31M | $14.19M | 2.46% | -$1.12M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 0 | 341,496 | +341,496 | $0 | $13.83M | 2.40% | +$13.83M |
| Dyne Therapeutics, Inc.(DYN) | 0 | 1,446,361 | +1,446,361 | $0 | $13.77M | 2.39% | +$13.77M |
| Vera Therapeutics, Inc.CL A(VERA) | 415,719 | 563,075 | +147,356 | $9.99M | $13.27M | 2.30% | +$3.28M |
| Crinetics Pharmaceuticals Inc. | 631,964 | 428,975 | -202,989 | $21.20M | $12.34M | 2.14% | -$8.86M |
| Revolution Medicines, Inc.(RVMD) | 317,083 | 315,722 | -1,361 | $11.21M | $11.62M | 2.01% | +$403.4K |
| Akebia Therapeutics, Inc.(AKBA) | 0 | 2,889,125 | +2,889,125 | $0 | $10.52M | 1.82% | +$10.52M |
| Olema Pharmaceuticals, Inc.(OLMA) | 2,930,446 | 2,378,762 | -551,684 | $11.02M | $10.13M | 1.76% | -$885.0K |
| Xenon Pharmaceuticals Inc.(XENE) | 303,398 | 323,398 | +20,000 | $10.18M | $10.12M | 1.75% | -$56.6K |
| Wave Life Sciences, Inc.(WVE) | 1,509,580 | 1,505,262 | -4,318 | $12.20M | $9.78M | 1.70% | -$2.41M |
| DBV Technologies S.A.ADS(DBVT) | 0 | 1,054,504 | +1,054,504 | $0 | $9.65M | 1.67% | +$9.65M |
| Context Therapeutics Inc.(CNTX) | 14,705,882 | 14,705,882 | 0 | $9.00M | $9.64M | 1.67% | +$635.3K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,618,265 | 3,903,081 | +2,284,816 | $10.79M | $9.56M | 1.66% | -$1.23M |
| Replimune Group, Inc.(REPL) | 987,036 | 983,780 | -3,256 | $9.62M | $9.14M | 1.58% | -$484.3K |
| Nuvation Bio Inc.(NUVB) | 4,652,243 | 4,622,590 | -29,653 | $8.19M | $9.01M | 1.56% | +$826.1K |
| Stoke Therapeutics, Inc.(STOK) | 693,988 | 789,698 | +95,710 | $4.62M | $8.96M | 1.55% | +$4.35M |
| Solid Biosciences Inc | 1,642,356 | 1,634,569 | -7,787 | $6.08M | $7.96M | 1.38% | +$1.88M |
| Relay Therapeutics, Inc.(RLAY) | 2,295,924 | 2,282,680 | -13,244 | $6.02M | $7.90M | 1.37% | +$1.88M |
| Cartesian Therapeutics, Inc.(RNAC) | 790,779 | 686,007 | -104,772 | $10.42M | $7.13M | 1.23% | -$3.29M |
| Taysha Gene Therapies, Inc.(TSHA) | 0 | 2,953,562 | +2,953,562 | $0 | $6.82M | 1.18% | +$6.82M |
| Sarepta Therapeutics, Inc.(SRPT) | 0 | 321,696 | +321,696 | $0 | $5.50M | 0.95% | +$5.50M |
| Soleno Therapeutics Inc | 0 | 50,000 | +50,000 | $0 | $4.19M | 0.73% | +$4.19M |
| Veru Inc.(VERU) | 6,592,727 | 4,911,948 | -1,680,779 | $3.23M | $2.86M | 0.50% | -$373.3K |
| Werewolf Therapeutics, Inc.(HOWL) | 2,408,810 | 2,408,810 | 0 | $2.34M | $2.63M | 0.45% | +$284.2K |
| Design Therapeutics, Inc.(DSGN) | 562,943 | 555,187 | -7,756 | $2.17M | $1.87M | 0.32% | -$302.0K |
| Repare Therapeutics, Inc. | 819,924 | 819,924 | 0 | $808.4K | $1.14M | 0.20% | +$331.2K |
| Adaptimmune Therapeutics plcADS(ADAPY) | 4,894,344 | 4,411,821 | -482,523 | $964.2K | $1.06M | 0.18% | +$93.3K |
| Arcellx Inc COMMON STOCK | 0 | 37 | +37 | $0 | $2.4K | 0.00% | +$2.4K |
| ALX Oncology Holdings Inc.(ALXO) | 550,000 | 0 | -550,000 | $342.6K | $0 | — | -$342.6K |
| IDEAYA Biosciences, Inc.(IDYA) | 430,161 | 0 | -430,161 | $7.05M | $0 | — | -$7.05M |
| Iovance Biotherapeutics, Inc.(IOVA) | 2,708,582 | 0 | -2,708,582 | $9.02M | $0 | — | -$9.02M |
| iTeos Therapeutics, Inc. | 1,745,943 | 0 | -1,745,943 | $10.42M | $0 | — | -$10.42M |
| Lantheus Holdings, Inc.(LNTH) | 232,387 | 0 | -232,387 | $22.68M | $0 | — | -$22.68M |
| Twist Bioscience Corporation(TWST) | 261,215 | 0 | -261,215 | $10.26M | $0 | — | -$10.26M |
| United Therapeutics Corporation(UTHR) | 58,907 | 0 | -58,907 | $18.16M | $0 | — | -$18.16M |